ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,708.80
-0.20%
S&P ASX All Technology
3,080.20
-0.40%
Brent Oil
82.09
-0.04%
US Dollar vs AUD
1.514
0.02%
Bitcoin
66,238.41
-0.60%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Sagiment Biosciences Inc (SGMT)

  7. Sagiment Biosciences Inc (SGMT) News

SGMT

Sagiment Biosciences (SGMT)

Sagiment Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SGMT
DateTimeSourceHeadlineSymbolCompany
13/06/202420:07Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:SGMTSagiment Biosciences Inc
08/06/202406:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGMTSagiment Biosciences Inc
08/06/202406:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGMTSagiment Biosciences Inc
06/06/202420:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGMTSagiment Biosciences Inc
23/05/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGMTSagiment Biosciences Inc
15/05/202422:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGMTSagiment Biosciences Inc
15/05/202421:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SGMTSagiment Biosciences Inc
09/05/202406:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGMTSagiment Biosciences Inc
09/05/202406:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SGMTSagiment Biosciences Inc
06/05/202422:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGMTSagiment Biosciences Inc
25/03/202422:00GlobeNewswire Inc.Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of DirectorsNASDAQ:SGMTSagiment Biosciences Inc
25/03/202421:15GlobeNewswire Inc.Sagimet Biosciences Reports Full Year 2023 Financial Results and Provides Corporate UpdatesNASDAQ:SGMTSagiment Biosciences Inc
01/03/202400:00GlobeNewswire Inc.Sagimet Biosciences to Participate in Two Upcoming Investor ConferencesNASDAQ:SGMTSagiment Biosciences Inc
15/02/202410:10Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SGMTSagiment Biosciences Inc
15/02/202408:37Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SGMTSagiment Biosciences Inc
06/02/202408:34Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SGMTSagiment Biosciences Inc
03/02/202408:36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGMTSagiment Biosciences Inc
03/02/202408:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SGMTSagiment Biosciences Inc
01/02/202408:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGMTSagiment Biosciences Inc
01/02/202408:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SGMTSagiment Biosciences Inc
31/01/202408:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGMTSagiment Biosciences Inc
26/01/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SGMTSagiment Biosciences Inc
26/01/202412:58GlobeNewswire Inc.Sagimet Biosciences Announces Pricing of Public Offering of Series A Common StockNASDAQ:SGMTSagiment Biosciences Inc
24/01/202422:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGMTSagiment Biosciences Inc
24/01/202422:08Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SGMTSagiment Biosciences Inc
24/01/202409:45GlobeNewswire Inc.Sagimet Biosciences Announces Proposed Public Offering of Series A Common StockNASDAQ:SGMTSagiment Biosciences Inc
24/01/202409:31Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SGMTSagiment Biosciences Inc
23/01/202400:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGMTSagiment Biosciences Inc
22/01/202423:00GlobeNewswire Inc.Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASHNASDAQ:SGMTSagiment Biosciences Inc
30/12/202308:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SGMTSagiment Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:SGMT

Your Recent History

NYSE
MCD
McDonalds
ASX
ANZ
Australia And New Zealan...
NASDAQ
AMZN
Amazon.com
FX
AUDUSD
AUD vs US Dollar
ASX
RIO
Rio Tinto
ASX
XAO
Australian SE All Ordina...
NASDAQ
AAPL
Apple
ASX
XTO
S&P ASX 100
ASX
FMG
Fortescue
ASX
WOW
Woolworths
COIN
ETHUSD
Ethereum
ASX
BHP
BHP
ASX
AMP
AMP
PM
XAUUSD
Gold vs US Dollar
ASX
XJO
S&P ASX 200
NYSE
DIS
Walt Disney
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved